Shingo Koyama
About
In The Last Decade
Shingo Koyama
43 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Physiology 650
- Geriatrics and Gerontology 237
- Clinical Psychology 190
- Psychiatry and Mental health 175
- Health 168
Countries citing papers authored by Shingo Koyama
This map shows the geographic impact of Shingo Koyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Koyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Koyama more than expected).
Fields of papers citing papers by Shingo Koyama
This network shows the impact of papers produced by Shingo Koyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Koyama. The network helps show where Shingo Koyama may publish in the future.
Co-authorship network of co-authors of Shingo Koyama
This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Koyama. A scholar is included among the top collaborators of Shingo Koyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Koyama. Shingo Koyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 17 | |
| 5 | 0 | |
| 6 | 18 | |
| 7 | 26 | |
| 8 | 19 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 195 | |
| 12 | 1 | |
| 13 | 21 | |
| 14 | 8 | |
| 15 | 11 | |
| 16 | 27 | |
| 17 | 25 | |
| 18 | 120 | |
| 19 | 15 | |
| 20 | A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients. | 29 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.